Doxazosin Tablet
Product Images NDC 68071-3298

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68071-3298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3298 03 A86)

Label for Doxazosin 4 mg tablets from NuCare Pharmaceuticals, Inc. The label indicates a package size of 30 tablets, noting each tablet contains Doxazosin mesylate equivalent to 4 mg Doxazosin USP. The tablets are capsule-shaped, white/off-white, and scored, with the imprint 'APO' on one side and '095' on the scored side. The label includes storage instructions to keep out of reach of children and store at controlled temperature 59-86°F.*

FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

Chemical structure of the active ingredient doxazosin, showing the molecular arrangement including aromatic rings, methoxy groups, piperazine ring, and sulfonic acid moiety in the formula.*

FDA Label Image

Figure1.jpg (Figure1)

Two line graphs comparing the effects of Doxazosin and placebo over 14 weeks. The first graph depicts mean change in total symptom score from baseline, showing a greater decrease with Doxazosin. The second graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, with higher increases for Doxazosin. Both graphs include sample sizes and indicate statistical significance.*

FDA Label Image

Table3.jpg (Table3)

A data table summarizing the effectiveness of doxazosin versus placebo in placebo-controlled trials, displaying symptom scores and maximum flow rates in three studies. It includes mean baseline values, mean changes, and sample sizes for placebo and doxazosin groups at different doses, alongside a bar graph illustrating maximum flow rate and symptom score changes in Study 2.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.